Skip to main content
. 2017 Dec 21;23(47):8405–8414. doi: 10.3748/wjg.v23.i47.8405

Table 5.

Univariate analysis of bleeding risk factors n (%)

Bleeding, n = 30 No bleeding, n = 278 P value
Age (yr), mean ± SD 69.5 ± 10 69.1 ± 12 0.137
Gender 0.634
Male 12 (40) 99 (35.6)
Female 18 (60) 179 (64.4)
Anticoagulation1 0.217
Yes 14 (46.7) 98 (35.2)
No 16 (53.3) 180 (64.7)
ASA 0.515
I, II 20 (66.7) 201 (72.3)
III, IV 10 (33.3) 77 (27.7)
Paris classification of polyps1
0-Ip 17 (56.7) 135 (48.6) 0.399
0-Is 13 (43.3) 143 (51.4)
Polyp size1 < 0.036
≤ 10 mm 7 (23) 120 (43.2)
> 10 mm 23 (77) 158 (56.8)
Location 0.557
Stomach 28 (93.3) 266 (95.7)
Duodenum 2 (6.7) 12 (4.3)
Polyp histology1 0.092
Hyperplastic 18 (60) 206 (74.4)
Others 12 (40) 72 (25.6)
Polyp with dysplasia 0.053
Yes 8 (26.7) 36 (13.4)
No 22 (73.3) 232 (86.6)
Physician expertise1 < 0.026
Staff 30 (100) 238 (85.6)
Fellow 0 (0) 40 (14.4)
University hospital 0.207
Yes 27 (90) 224 (80.6)
No 3 (10) 54 (19.4)
Number of polyps resected 0.989
One 20 (66.7) 185 (66.5)
More than one 10 (33.3) 93 (33.4)
Use of endocut1 0.068
Yes 27 (90) 209 (75.2)
No 3 (10) 69 (24.8)
Hemorrhage prophylaxis1 0.479
Yes 23 (76.7) 196 (70.5)
No 7 (23.3) 82 (29.5)
1

Clinically relevant variables that have been included in the multivariate analysis.